123 related articles for article (PubMed ID: 8662901)
1. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3.
Heding A; Gill R; Ogawa Y; De Meyts P; Shymko RM
J Biol Chem; 1996 Jun; 271(24):13948-52. PubMed ID: 8662901
[TBL] [Abstract][Full Text] [Related]
2. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor.
Vorwerk P; Hohmann B; Oh Y; Rosenfeld RG; Shymko RM
Endocrinology; 2002 May; 143(5):1677-85. PubMed ID: 11956149
[TBL] [Abstract][Full Text] [Related]
3. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
Lee CY; Rechler MM
Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit.
Twigg SM; Baxter RC
J Biol Chem; 1998 Mar; 273(11):6074-9. PubMed ID: 9497324
[TBL] [Abstract][Full Text] [Related]
6. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit.
Twigg SM; Hardman KV; Baxter RC
Growth Horm IGF Res; 2000 Aug; 10(4):215-23. PubMed ID: 11032705
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein-3: factors affecting binary and ternary complex formation.
Holman SR; Baxter RC
Growth Regul; 1996 Mar; 6(1):42-7. PubMed ID: 8717449
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
[TBL] [Abstract][Full Text] [Related]
9. Interaction of insulin-like growth factor II (IGF-II) with multiple plasma proteins: high affinity binding of plasminogen to IGF-II and IGF-binding protein-3.
Oesterreicher S; Blum WF; Schmidt B; Braulke T; Kübler B
J Biol Chem; 2005 Mar; 280(11):9994-10000. PubMed ID: 15642732
[TBL] [Abstract][Full Text] [Related]
10. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins.
Wong MS; Fong CC; Yang M
Biochim Biophys Acta; 1999 Jul; 1432(2):293-301. PubMed ID: 10407151
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase assay for insulin-like growth factor (IGF) binding to IGF-binding protein-3: application to the study of the effects of antibodies and heparin.
Koedam JA; Hoogerbrugge CM; van Buul-Offers SC; Van den Brande JL
J Endocrinol; 1997 Apr; 153(1):87-97. PubMed ID: 9135573
[TBL] [Abstract][Full Text] [Related]
12. Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit.
Hashimoto R; Ono M; Fujiwara H; Higashihashi N; Yoshida M; Enjoh-Kimura T; Sakano K
J Biol Chem; 1997 Oct; 272(44):27936-42. PubMed ID: 9346943
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3.
Firth SM; Ganeshprasad U; Baxter RC
J Biol Chem; 1998 Jan; 273(5):2631-8. PubMed ID: 9446566
[TBL] [Abstract][Full Text] [Related]
14. Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions.
Payet LD; Wang XH; Baxter RC; Firth SM
Endocrinology; 2003 Jul; 144(7):2797-806. PubMed ID: 12810533
[TBL] [Abstract][Full Text] [Related]
15. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.
Yan X; Forbes BE; McNeil KA; Baxter RC; Firth SM
J Biol Chem; 2004 Dec; 279(51):53232-40. PubMed ID: 15485880
[TBL] [Abstract][Full Text] [Related]
16. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
17. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein (IGFBP)-3-bound IGF-I and IGFBP-3-bound IGF-II in growth hormone deficiency.
Belgorosky A; Rivarola MA
Horm Res; 1999; 52(2):60-5. PubMed ID: 10681634
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factors (IGFs) I and II bind to articular cartilage via the IGF-binding proteins.
Bhakta NR; Garcia AM; Frank EH; Grodzinsky AJ; Morales TI
J Biol Chem; 2000 Feb; 275(8):5860-6. PubMed ID: 10681577
[TBL] [Abstract][Full Text] [Related]
20. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions.
Imai Y; Moralez A; Andag U; Clarke JB; Busby WH; Clemmons DR
J Biol Chem; 2000 Jun; 275(24):18188-94. PubMed ID: 10766744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
